A Pre-Vaccination Baseline of SARS-CoV-2 Genetic Surveillance and Diversity in the United States

COVID-19 vaccines were first administered on 15 December 2020, marking an important transition point for the spread of SARS-CoV-2 in the United States (U.S.). Prior to this point in time, the virus spread to an almost completely immunologically naïve population, whereas subsequently, vaccine-induced...

Descripción completa

Detalles Bibliográficos
Autores principales: Capoferri, Adam A., Shao, Wei, Spindler, Jon, Coffin, John M., Rausch, Jason W., Kearney, Mary F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778900/
https://www.ncbi.nlm.nih.gov/pubmed/35062308
http://dx.doi.org/10.3390/v14010104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8778900/
https://www.ncbi.nlm.nih.gov/pubmed/35062308
http://dx.doi.org/10.3390/v14010104

Ejemplares similares